The University of Chicago Header Logo

Connection

Everett E. Vokes to Programmed Cell Death 1 Receptor

Back to Details
This is a "connection" page, showing publications Everett E. Vokes has written about Programmed Cell Death 1 Receptor.
Everett E. Vokes
Connection Strength
0.069
Programmed Cell Death 1 Receptor
  1. Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use. Clin Cancer Res. 2019 09 01; 25(17):5221-5230.
    View in: PubMed
    Score: 0.039
  2. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer. N Engl J Med. 2015 Jul 09; 373(2):123-35.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.